Summary: New research explains how common chemicals in cosmetics and lotions displace natural lipids in skin immune cells, revealing a likely cause of allergic contact dermatitis and pointing to possible new treatments.
Source: Columbia University
Allergic contact dermatitis, a rising concern, can be triggered by many chemicals in creams, cosmetics, and other topical products. Until now, the precise mechanism by which many small molecules provoke T cell–mediated skin allergies has been unclear.
Researchers report that several widely used ingredients can displace the skin’s natural fat-like molecules (lipids) inside an immune-presenting protein, CD1a, on Langerhans cells. This displacement exposes CD1a to T cells and activates an immune response, providing a plausible explanation for how nonpeptidic skin chemicals cause allergic contact dermatitis and suggesting novel approaches to prevent or treat these reactions.
The study was conducted by teams at Columbia University Irving Medical Center, Brigham and Women’s Hospital, and Monash University, and the findings were published in Science Immunology.
Why many small chemicals trigger dermatitis has been a puzzle
Allergic contact dermatitis is commonly associated with exposures such as poison ivy, but many everyday products—including skin creams, fragrances, and toothpaste—contain small chemical compounds that can cause similar itchy rashes. Typically, T cells recognize foreign substances only when those substances are presented as part of larger protein or lipid complexes. Yet many contact allergens are small and lack the chemical groups thought necessary to form such complexes, so how they become visible to T cells has been uncertain.
“Many small molecules in skincare products should be invisible to T cells because they cannot chemically modify proteins,” says co-leader Annemieke de Jong, PhD, assistant professor of dermatology at Columbia University Vagelos College of Physicians and Surgeons. “But they clearly trigger immune responses in people, so another mechanism must be at work.”
Langerhans cells and CD1a unmask allergy-inducing chemicals
The investigators focused on CD1a, an MHC I–like molecule abundant on Langerhans cells in the skin’s outer layer. Using human T cell clones in tissue culture, they screened a range of clinically relevant allergens and found that several common compounds bind to CD1a and activate T cells.
Among the compounds identified were components of Balsam of Peru and farnesol—ingredients commonly present in personal care products such as creams, fragrances, and toothpaste. Further analysis isolated benzyl benzoate and benzyl cinnamate within Balsam of Peru as specific agents that trigger CD1a-dependent T cell responses. In total, the team identified more than a dozen small, highly hydrophobic chemicals that can activate T cells via CD1a.
“These laboratory results show how particular chemicals can activate T cells when presented by CD1a, although additional studies are needed to confirm the mechanism directly in patients with allergic contact dermatitis,” de Jong cautions. “The findings do, however, suggest strategies for follow-up clinical work and for designing inhibitors to block the response.”
Mechanism: displacement of natural lipids exposes CD1a to T cells
Under normal conditions, CD1a binds the skin’s endogenous lipids within a tunnel-shaped pocket. Portions of these lipids protrude from CD1a and form a barrier that prevents T cell receptors from recognizing the protein’s surface. Structural studies from Monash University revealed that certain small allergens, such as farnesol, can slip deeply into CD1a’s tunnel and displace the natural lipids that normally protrude.
When these self-lipids are displaced, the CD1a surface becomes unmasked and accessible to T cell receptors, triggering an immune response. This “displacement and unmasking” mechanism explains how small, nonpeptidic, highly hydrophobic molecules can provoke T cell activation without covalently modifying proteins.
Implications for prevention and treatment
The discovery points toward a potential therapeutic approach that would not rely solely on avoiding the offending chemical. Because CD1a naturally binds a variety of skin lipids, applying non-stimulatory lipids that compete for CD1a binding could prevent displacement by allergenic molecules and keep CD1a shielded from T cells. Some endogenous lipids are known to bind CD1a without activating T cells, raising the possibility of topical formulations that restore or preserve the protective lipid barrier on CD1a.
Currently, management of allergic contact dermatitis focuses on identifying and avoiding the trigger. Topical treatments and emollients can soothe symptoms, and rashes often resolve within weeks. In more severe cases, systemic corticosteroids or other immunosuppressive therapies may be used, but these carry risks such as increased susceptibility to infection. A targeted lipid-based topical strategy could reduce reliance on systemic immunosuppression and limit side effects.
Study leadership and contributors
The study was co-led by Annemieke de Jong (Columbia University), Jamie Rossjohn (Monash University and Cardiff University School of Medicine), and D. Branch Moody (Brigham and Women’s Hospital, Harvard Medical School). Other contributors included researchers from Brigham and Women’s Hospital, Monash University, and Columbia University.
Funding and disclosures
The work was supported by grants from the National Institutes of Health, the National Health and Medical Research Council of Australia, the Australian Research Council, the Irving Institute for Clinical and Translational Research at Columbia University, and the Wellcome Trust. The authors report no competing interests.
Research article
Original research: “Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products.” The study characterizes how small, hydrophobic chemicals in consumer products can be recognized via CD1a by human T cells and defines chemical properties—small size, high hydrophobicity, and structural rigidity—that favor CD1a-mediated responses. The findings offer a molecular explanation for many T cell–mediated reactions to oily substances in everyday products and suggest new directions for prevention and treatment of allergic contact dermatitis.